Braido, Fulvio <br/><br/>
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial.  [electronic resource] 

 -  Immunology letters  Dec 2014 
 - 185-93 p.  digital 
<br/><br/> Publication Type: Historical Article; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0542 
<br/><br/><label>Standard No.: </label>10.1016/j.imlet.2014.10.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Antigens, Bacterial--administration & dosage<br/>Asthma--drug therapy<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>History, Ancient<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Respiratory Tract Infections--drug therapy<br/>Severity of Illness Index